Motus GI (MOTS) Stock Price, News & Analysis

Company Overview

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Key Stats

• Today's Range: $0.03 to $0.04
• 50-Day Range: $0.02 to $0.07
• 52-Week Range: $0.02 to $10.05
• Volume: 23,003 shs
• Average Volume: 647,328 shs
• Market Capitalization: $227,298.60
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MOTS Stock Analysis - Frequently Asked Questions

How have MOTS shares performed this year?

Motus GI's stock was trading at $1.2750 on January 1st, 2024. Since then, MOTS stock has decreased by 96.9% and is now trading at $0.0394.
View the best growth stocks for 2024 here.

How were Motus GI's earnings last quarter?

Motus GI Holdings, Inc. (NASDAQ:MOTS) posted its earnings results on Friday, November, 12th. The company reported ($30.00) EPS for the quarter, hitting the consensus estimate of ($30.00). The firm earned $0.14 million during the quarter, compared to analyst estimates of $0.12 million. Motus GI had a negative net margin of 3,239.75% and a negative trailing twelve-month return on equity of 1,731.08%.

When did Motus GI's stock split?

Motus GI's stock reverse split before market open on Thursday, November 2nd 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Motus GI IPO?

Motus GI (MOTS) raised $21 million in an initial public offering (IPO) on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

How do I buy shares of Motus GI?

Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Motus GI own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Motus GI investors own include Matinas BioPharma (MTNB), Allena Pharmaceuticals (ALNA), VYNE Therapeutics (VYNE), Rigel Pharmaceuticals (RIGL), TherapeuticsMD (TXMD), Sorrento Therapeutics (SRNE) and Pfizer (PFE).

Company Calendar

• Last Earnings: 11/12/2021
• Today: 10/05/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:MOTS
• CUSIP: N/A
• CIK: 1686850
• Web: www.motusgi.com
• Phone: (954) 541-8000
• Fax: 954-541-8265
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($15.64)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-12,870,000.00
• Net Margins: -3,239.75%
• Pretax Margin: -3,239.75%
• Return on Equity: -1,731.08%
• Return on Assets: -115.99%

Debt

• Debt-to-Equity Ratio: 0.22
• Current Ratio: 1.74
• Quick Ratio: 1.67

Sales & Book Value

• Annual Sales: $319,000.00
• Price / Sales: 0.71
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.74 per share
• Price / Book: 0.02

Miscellaneous

• Outstanding Shares: 5,769,000
• Free Float: 5,749,000
• Market Cap: $227,298.60
• Optionable: Not Optionable
• Beta: 1.81